Psychosom Med. 2023 Aug 7. doi: 10.1097/PSY.0000000000001242. Online ahead of print.
ABSTRACT
OBJECTIVE: eHealth is a useful tool to deliver lifestyle interventions for patients with cardiometabolic diseases. However, there are inconsistent findings about whether these eHealth interventions should be supported by a human professional, or whether self-help interventions are equally effective.
METHODS: Databases were searched between January 1995 and October 2021 for randomized controlled trials on cardiometabolic diseases (cardiovascular disease, chronic kidney disease, type 1 and 2 diabetes mellitus) and eHealth lifestyle interventions. A multilevel meta-analysis was used to pool clinical and behavioral health outcomes. Moderator analyses assessed the effect of intervention type (self-help vs. human-supported), dose of human support (minor vs. major part of intervention), and delivery mode of human support (remote vs. blended). 107 papers fulfilled eligibility criteria and 102 unique (N = 20,781) studies were included.
RESULTS: The analysis showed a positive effect of eHealth lifestyle interventions on clinical and behavioral health outcomes (p < .001). However, these effects were not moderated by intervention type (p = .169), dose (p = .698), or delivery mode of human support (p = .557).
CONCLUSION: This shows that self-help eHealth interventions are equally effective as human-supported ones in improving health outcomes among cardiometabolic disease patients. Future studies could investigate whether higher quality eHealth interventions compensate for a lack of human support.Meta-analysis registration: PROSPERO CRD42021269263.
PMID:37549197 | DOI:10.1097/PSY.0000000000001242
